InnoCare Pharma Wins Singapore HSA Approval for HIBRUKA Orelabrutinib in Relapsed or Refractory Marginal Zone Lymphoma

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, announced today that HIBRUKA ...

September 09, 2025 | Tuesday | News
Johnson & Johnson Expands ACUVUE® Portfolio with Breakthrough Toric Lenses in Europe and Middle East

World’s #1 Selling Contact Lens Brand ACUVUE® brings pioneering innovation for astigmatic patients, providing visual clarity and comfort Johns...

September 08, 2025 | Monday | News
Daiichi Sankyo and Merck Report Positive Phase 2 Results for Ifinatamab Deruxtecan in Extensive-Stage Small Cell Lung Cancer

Daiichi Sankyo (TSE: 4568) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive results from the Phase 2...

September 08, 2025 | Monday | News
Science 37 and Catalent Partner to Transform Clinical Trial Access with Direct-to-Patient IMP Delivery

Science 37, the leader in expanding patient access to clinical trials, and Catalent®, a global leader in enabling pharma, biotech, and consumer healt...

September 05, 2025 | Friday | News
Andelyn Biosciences Partners with Tern Therapeutics to Advance Late-Stage Manufacturing of Gene Therapy for CLN2 Batten Disease

Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered...

September 05, 2025 | Friday | News
Gilead Breaks Ground on $32 Billion U.S. Innovation Commitment with New Technical Development Center in Foster City

Gilead Sciences celebrates the groundbreaking of its new Pharmaceutical Development and Manufacturing (PDM) Technical Development Center (NTDC) at the co...

September 04, 2025 | Thursday | News
Amgen to Invest $600 Million in New Science and Innovation Center at U.S. Headquarters

Research and Development Infrastructure Investment Expected to Create Hundreds of U.S. Jobs   Amgen  announced plans to invest more than ...

September 04, 2025 | Thursday | News
How Does A PCR Technique Detect The Monkeypox Virus?

  According to recent statistics, the WHO (World Health Organization) has conducted an assessment of mpox cases in Africa, which showed that, as of 2...

September 03, 2025 | Wednesday | News
New Jersey: A Leading Life Sciences Manufacturing Hub

New Jersey at a Glance – Often dubbed the “Medicine Chest of the World,” New Jersey has a rich legacy and a dynamic present as a global h...

September 03, 2025 | Wednesday | Reports
Ryvu Partners with BioNTech to Accelerate Oncology Clinical Trial Access in Poland

Ryvu to support BioNTech in the acceleration of site activation and enrollment of patients for multiple of BioNTech’s priority oncology clin...

September 03, 2025 | Wednesday | News
Boehringer Ingelheim’s HERNEXEOS® (zongertinib) Receives NMPA Approval for HER2-Mutant Advanced NSCLC in China

Boehringer Ingelheim  announced that China’s National Medical Products Administration (NMPA) has approved HERNEXEOS® (zongertinib tablets)...

September 02, 2025 | Tuesday | News
Roche and Alnylam Target Uncontrolled Hypertension with ZENITH Phase III Trial

Phase III trial informed by comprehensive KARDIA data set generated through three Phase II studies: KARDIA-1, KARDIA-2 and KARDIA-3 In the Phase II KA...

September 02, 2025 | Tuesday | News
Zai Lab Secures Hong Kong Approval for TIVDAK in Advanced Cervical Cancer

Zai Lab announced the Hong Kong Department of Health has approved TIVDAK (tisotumab vedotin-tftv) in Hong Kong for the treatment of adult patients with r...

September 02, 2025 | Tuesday | News
Foresight Diagnostics Reaches Licensing Agreement with Roche on PhasED-Seq™, Resolving Litigation

Foresight Diagnostics ("Foresight") announced that it has entered into a limited licensing agreement with Roche Molecular Systems and Roche Sequencing Sy...

September 01, 2025 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close